Medindia

X

Multiple Sclerosis Patients Can Now Walk Faster with Newly Approved Drug in US

by Thilaka Ravi on  January 25, 2010 at 12:27 PM Drug News   - G J E 4
The US Food and Drug Administration (FDA) has approved a drug which has been found to allow patients with multiple sclerosis (MS) walk faster, the drug watchdog said.
Multiple Sclerosis Patients Can Now Walk Faster with Newly Approved Drug in US
Multiple Sclerosis Patients Can Now Walk Faster with Newly Approved Drug in US
Advertisement

Multiple sclerosis patients treated with the drug, Ampyra - generic name dalfampridine - were found in clinical trials to have faster walking speeds than those treated with a placebo, the FDA said.

Advertisement
"Trouble with walking is one of the most debilitating problems people with MS face," Russell Katz, director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research, said in a statement Saturday.

Ampyra is the first drug approved by the FDA to help improve MS patients' walking.

Multiple sclerosis is a chronic, often disabling disease that affects the brain, spinal cord and optic nerves.

Around 2.5 million people worldwide, including 400,000 in the United States, have MS, according to Multiple Sclerosis Society.

Source: AFP
THK
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All